# FDA 483 - NEURELEC - June 02, 2022

Source: https://www.globalkeysolutions.net/records/483/neurelec/431939d0-f8d5-49e8-a318-fb384bc0dc5f

> FDA 483 for NEURELEC on June 02, 2022. Product: device. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: NEURELEC
- Inspection Date: 2022-06-02
- Product Type: device
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/neurelec/460ed7e4-d115-4d97-b904-8a4844646b1b)
- [483 - 2022-06-02](https://www.globalkeysolutions.net/records/483/neurelec/05bf3b2c-5d95-4592-be17-6cb4cac34e5a)
- [483 - 2022-06-02](https://www.globalkeysolutions.net/records/483/neurelec/0deaaf2a-1c0a-496b-bf59-ad0e9f4b7db9)
- [483 - 2022-06-02](https://www.globalkeysolutions.net/records/483/neurelec/0405d882-4eda-4800-afba-ac5a9ee7aef4)
- [483 - 2022-06-02](https://www.globalkeysolutions.net/records/483/neurelec/9e5c4a1f-ba0c-4c94-996d-bf9287452b54)

## Related Officers

- [Consumer Safety Officer](https://www.globalkeysolutions.net/people/catherine-j-laufmann/920b7656-2847-408d-ba15-3989283d8c94)

Company: https://www.globalkeysolutions.net/companies/neurelec/7e121ac2-8de5-4034-b39b-f4768d711b5d

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd